GE HealthCare’s Flyrcado PET radiotracer secures FDA approval
GE HealthCare secured exclusive worldwide commercialisation rights to flurpiridaz F 18 from Lantheus. Credit: GE HealthCare / Business Wire. GE...
GE HealthCare secured exclusive worldwide commercialisation rights to flurpiridaz F 18 from Lantheus. Credit: GE HealthCare / Business Wire. GE...